Related Experiment Video
Updated: Sep 22, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
The Hippo pathway mediates Semaphorin signaling
Zhipeng Meng1,2,3, Fu-Long Li1, Cao Fang1
1Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
Insights
Class 3 Semaphorins (SEMA3s) activate the Hippo pathway to inhibit tissue growth, angiogenesis, and tumor formation. This discovery reveals a new mechanism for SEMA3s in regulating biological processes.
Area of Science:
- Cell biology
- Molecular biology
- Cancer research
Background:
- Semaphorins are known for axonal guidance but also influence vascular development and tumorigenesis.
- The precise signaling pathways of Semaphorins in these processes are not fully understood.
Purpose of the Study:
- To investigate the downstream signaling cascades of Semaphorins, specifically Class 3 Semaphorins (SEMA3s).
- To determine the role of SEMA3s in regulating tissue growth, angiogenesis, and tumorigenesis through the Hippo pathway.
Main Methods:
- Investigated SEMA3B restoration in lung cancer cells.
- Analyzed the interaction between SEMA3A receptor PlexinA and p190RhoGAPs.
- Studied the activation of Hippo kinases LATS1/2.
Main Results:
- Class 3 Semaphorins (SEMA3s) activate the Hippo pathway to suppress tissue growth, angiogenesis, and tumorigenesis.
- SEMA3B restoration inhibited lung cancer cell growth by activating LATS1/2.
- SEMA3s inhibit angiogenesis via LATS1/2 activation.
- p190RhoGAPs act as key partners for PlexinA in Hippo pathway regulation.
- SEMA3 signaling activates p190RhoGAP, leading to LATS1/2 stimulation.
Conclusions:
- Class 3 Semaphorins (SEMA3s) utilize the Hippo pathway to control fundamental biological processes.
- The SEMA3-PlexinA-p190RhoGAP axis is critical for Hippo pathway activation.
- Disease-associated factors can disrupt SEMA3-mediated Hippo pathway regulation.
Abstract:
Semaphorins were originally identified as axonal guidance molecules, but they also control processes such as vascular development and tumorigenesis. The downstream signaling cascades of Semaphorins in these biological processes remain unclear. Here, we show that the class 3 Semaphorins (SEMA3s) activate the Hippo pathway to attenuate tissue growth, angiogenesis, and tumorigenesis. SEMA3B restoration in lung cancer cells with SEMA3B loss of heterozygosity suppresses cancer cell growth via activating the core Hippo kinases LATS1/2 (large tumor suppressor kinase 1/2). Furthermore, SEMA3 also acts through LATS1/2 to inhibit angiogenesis. We identified p190RhoGAPs as essential partners of the SEMA3A receptor PlexinA in Hippo regulation. Upon SEMA3 treatment, PlexinA interacts with the pseudo-guanosine triphosphatase (GTPase) domain of p190RhoGAP and simultaneously recruits RND GTPases to activate p190RhoGAP, which then stimulates LATS1/2. Disease-associated etiological factors, such as genetic lesions and oscillatory shear, diminish Hippo pathway regulation by SEMA3. Our study thus discovers a critical role of Hippo signaling in mediating SEMA3 physiological function.
Related Concept Videos
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The JAK-STAT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

